{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:15:34Z","timestamp":1787508934902,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"am","delay-in-days":284,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019480","name":"North Carolina General Assembly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmc.2025.118384","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T23:58:58Z","timestamp":1757375938000},"page":"118384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel tricycle expanded purine nucleosides with pan-viral activity"],"prefix":"10.1016","volume":"130","author":[{"given":"C\u00e9line","family":"Martin-Ghoteimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayane","family":"Ghoteimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meareg","family":"Amare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan V.","family":"Diefenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianna","family":"Kutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egor","family":"Tchesnokov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Denison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"G\u00f6tte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Halfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec J.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Sheahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Seley-Radtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.bmc.2025.118384_bb0005","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1021\/ol0165443","article-title":"Design and synthesis of two novel split nucleosides","volume":"3","author":"Seley","year":"2001","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2025.118384_bb0010","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1021\/jo0255476","article-title":"\u201cFleximers\u201d. Design and synthesis of a new class of novel shape-modified nucleosides","volume":"67","author":"Seley","year":"2002","journal-title":"J Organomet Chem"},{"issue":"13","key":"10.1016\/j.bmc.2025.118384_bb0015","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1021\/ja00429a040","article-title":"Defined dimensional changes in enzyme substrates and cofactors. Synthesis of lin-Benzoadenosine and enzymatic evaluation of derivatives of the Benzopurines","volume":"98","author":"Leonard","year":"1976","journal-title":"J Am Chem Soc"},{"issue":"48","key":"10.1016\/j.bmc.2025.118384_bb0020","doi-asserted-by":"crossref","first-page":"10791","DOI":"10.1016\/j.tet.2008.09.011","article-title":"Mechanistic studies in the synthesis of a series of thieno-expanded xanthosine and guanosine nucleosides","volume":"64","author":"Zhang","year":"2008","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmc.2025.118384_bb0025","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1021\/jm000326i","article-title":"Synthesis and antitumor activity of Thieno-separated tricyclic purines","volume":"43","author":"Seley","year":"2000","journal-title":"J Med Chem"},{"issue":"20","key":"10.1016\/j.bmc.2025.118384_bb0030","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1021\/ol101482h","article-title":"Tricyclic 2\u2032-C-modified nucleosides as potential anti- HCV therapeutics","volume":"12","author":"Wauchope","year":"2010","journal-title":"Org Lett"},{"issue":"8","key":"10.1016\/j.bmc.2025.118384_bb0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/acsinfecdis.5b00029","article-title":"Bicyclic and tricyclic \u201cexpanded\u201d nucleobase analogues of Sofosbuvir: new scaffolds for hepatitis C therapies","volume":"1","author":"Chen","year":"2015","journal-title":"ACS Infectious Diseases"},{"issue":"19","key":"10.1016\/j.bmc.2025.118384_bb0040","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1016\/j.bmcl.2015.07.086","article-title":"Thiophene-expanded guanosine analogues of gemcitabine","volume":"25","author":"Chen","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2025.118384_bb0045","doi-asserted-by":"crossref","unstructured":"Shannon, A.; Fattorini, V.; Sama, B.; Selisko, B.; Feracci, M.; Falcou, C.; Gauffre, P.; El Kazzi, P.; Delpal, A.; Decroly, E.; et al. A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase. Nature Communications 2022, 13 (1). DOI: 10.1038\/s41467-022-28113-1 (accessed 2024\u201310-09T23:26:06).","DOI":"10.1038\/s41467-022-28113-1"},{"issue":"8","key":"10.1016\/j.bmc.2025.118384_bb0050","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1021\/jm950605j","article-title":"Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite","volume":"39","author":"McGuigan","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118384_bb0055","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.1021\/jm060776w","article-title":"Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives","volume":"49","author":"McGuigan","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118384_bb0060","first-page":"61 (6)","article-title":"The ProTide prodrug technology: from the concept to the clinic","author":"Mehellou","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118384_bb0065","doi-asserted-by":"crossref","DOI":"10.1177\/2040206618775243","article-title":"Phosphoramidates and phosphonamidates (ProTides) with antiviral activity","volume":"26","author":"Slusarczyk","year":"2018","journal-title":"Antivir Chem Chemother"},{"issue":"5","key":"10.1016\/j.bmc.2025.118384_bb0070","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1021\/jm400201a","article-title":"Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients","volume":"57","author":"Cho","year":"2014","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2025.118384_bb0075","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1128\/AAC.02351-13","article-title":"Inhibition of hepatitis C virus replication by GS-6620, a potent C nucleoside monophosphate prodrug","volume":"58","author":"Feng","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"22","key":"10.1016\/j.bmc.2025.118384_bb0080","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1055\/s-0032-1316791","article-title":"Synthetic routes to a series of proximal and distal 2\u2032-deoxy Fleximers","volume":"44","author":"Wauchope","year":"2012","journal-title":"Synthesis"},{"issue":"22","key":"10.1016\/j.bmc.2025.118384_bb0085","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1021\/jm070362i","article-title":"First example of phosphoramidate approach applied to a 4\u2032-substituted purine nucleoside (4\u2032-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus","volume":"50","author":"Perrone","year":"2007","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.bmc.2025.118384_bb0090","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1021\/jm0613370","article-title":"Application of the phosphoramidate ProTide approach to 4\u2032-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside","volume":"50","author":"Perrone","year":"2007","journal-title":"J Med Chem"},{"issue":"20","key":"10.1016\/j.bmc.2025.118384_bb0095","doi-asserted-by":"crossref","first-page":"8311","DOI":"10.1021\/jo201492m","article-title":"Synthesis of diastereomerically pure nucleotide phosphoramidates","volume":"76","author":"Ross","year":"2011","journal-title":"J Organomet Chem"},{"issue":"35","key":"10.1016\/j.bmc.2025.118384_bb0100","doi-asserted-by":"crossref","first-page":"20113","DOI":"10.1039\/C9RA01754B","article-title":"Microwave-assisted organic synthesis of nucleoside ProTide analogues","volume":"9","author":"Bordoni","year":"2019","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2025.118384_bb0105","unstructured":"https:\/\/www.niaid.nih.gov\/research\/antiviral-drug-discovery-centers-pathogens-pandemic-concern (accessed)."},{"issue":"4","key":"10.1016\/j.bmc.2025.118384_bb0110","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1073\/pnas.0708057105","article-title":"Generation of biologically contained Ebola viruses","volume":"105","author":"Halfmann","year":"2008","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"10.1016\/j.bmc.2025.118384_bb0115","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/acs.jcim.7b00315","article-title":"Developing collaborative QSAR models without sharing structures","volume":"57","author":"Gedeck","year":"2017","journal-title":"J Chem Inf Model"},{"issue":"2","key":"10.1016\/j.bmc.2025.118384_bb0120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","article-title":"SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract","volume":"182","author":"Hou","year":"2020","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.bmc.2025.118384_bb0125","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J Biol Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:58:00Z","timestamp":1762347480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625003256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"alternative-id":["S0968089625003256"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118384","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel tricycle expanded purine nucleosides with pan-viral activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118384"}}